(3s,4s)-7-hydroxy-___-tetra-hydrocannabinol homologes and derivatives
CA 1286682 C · Owner: Yissum Research Development Company Of The Hebrew University In Jerusale M · Inventors: Lander, Naphtali; Srebnik, Morris; Feigenbaum, Jeffery
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel (3S,4S)-7-hydroxy-.DELTA.6-tetrahydrocannabinol homologes and derivatives essentially free of, the (3R,4R) form and to pharmaceutical compositions which have a potent analgetic, antiemetic and antiglaucoma effect which, compositions contain an effective dosage of a compound of this type. The novel pharmaceutical compositions are practically devoid of the undesired side effects of the (3R,4R) type compounds such as, cannabimimetic psychotropic effects. The pharmaceutical compositions are of special utility in cases of acute and of chronic pain. The invention also relates to a process for the production of the above defined novel compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 23, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 23, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.